Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1700 of 3173 entries
View as:

PK Study in Adult Healthy Volunteers to Assess QD Dosing With the Selected Age-appropriate MR Formulations

Phase: N/A Priority: Normal
NCT ID: NCT03112148 Org: User:
Start: 09/11/17 End: 11/15/17 Due: 11/15/18

A Study to Assess Immune Response Following Zoster Vaccination to Subjects With Rheumatoid Arthritis Receiving Tofacitinib or Placebo With Background Methotrexate

Phase: N/A Priority: Normal
NCT ID: NCT02147587 Org: User:
Start: 06/30/14 End: 07/31/15 Due: 07/31/16

A Randomized Double Blind, Placebo Controlled Balanced 4-Way Crossover Study To Assess The Efficacy Of Single Oral Doses

Phase: N/A Priority: Normal
NCT ID: NCT00273416 Org: User:
Start: 01/31/06 End: - Due: -

A Clinical Study To Characterize The Pharmacokinetics And The Effects Of Food On Oxycodone In Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01530542 Org: User:
Start: 07/31/10 End: 09/30/10 Due: 09/30/11

Sunitinib Plus Prednisone In Patients With Metastatic Castration-Resistant Prostate Cancer After Failure Of Docetaxel Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00676650 Org: User:
Start: 07/31/08 End: 12/31/11 Due: 12/31/12

Randomized Study Of Exercise And Vitamin D In Frail Elderly Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00249704 Org: User:
Start: 10/31/05 End: 01/31/08 Due: 01/31/09

Real World-clinical Outcomes of Tucatinib, Trastuzumab, and Capecitabine Following Trastuzumab Deruxtecan (T-DXd) for the Treatment of HER2-positive Metastatic Breast Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT06961331 Org: User:
Start: 05/07/25 End: 07/01/25 Due: 07/01/26

A Study To Investigate How The Body Handles Multiple Doses Of PF-0243873 And To Investigate The Effect Of PF-02413873 On Sex Hormone Levels In Healthy Young Women

Phase: N/A Priority: Normal
NCT ID: NCT00800618 Org: User:
Start: 11/30/08 End: 06/30/09 Due: 06/30/10

A Phase 1 Study Of PF-00868554 In Hepatitis C Virus (HCV) Positive Patients

Phase: N/A Priority: Normal
NCT ID: NCT00445315 Org: User:
Start: 01/31/07 End: 06/30/08 Due: 06/30/09

Long-Term Use Of Pegaptanib In Patients For Subfoveal Choroidal Neovascularization Secondary To Age-Related Macular Degeneration

Phase: N/A Priority: Normal
NCT ID: NCT00845273 Org: User:
Start: 11/30/08 End: 02/28/14 Due: 02/28/15

A Study To Assess The Effect Of PF-03526299 On Lung Function Following An Allergen Challenge In Asthmatic Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00877539 Org: User:
Start: 06/30/09 End: 07/31/10 Due: 07/31/11

A Study For Patients With EGFRm (Epidermal Growth Factor Receptor Mutant) Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02297425 Org: User:
Start: 01/31/15 End: 03/31/18 Due: 03/31/19

A Study of PF-07820435 as a Single Agent and in Combination in Participants With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06285097 Org: User:
Start: 02/08/24 End: 01/03/25 Due: 01/03/26

A Study to Assess the Safety and Efficacy Of Tafamidis In Chinese Participants With Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

Phase: N/A Priority: Normal
NCT ID: NCT04814186 Org: User:
Start: 07/22/21 End: 10/16/23 Due: 10/16/24

A Study to Learn How Renal Impairment Affects the Pharmacokinetics of PF-07817883.

Phase: N/A Priority: Normal
NCT ID: NCT06586216 Org: User:
Start: 09/10/24 End: 02/13/25 Due: 02/13/26

Study To Determine The Effects And Safety Of A Weight Loss Compound On Overweight, Otherwise Healthy, Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00479492 Org: User:
Start: 06/30/07 End: 01/31/08 Due: 01/31/09

Safety and Efficacy of EXC 001 in Subjects Who Have Participated in Prior Studies of EXC 001

Phase: N/A Priority: Normal
NCT ID: NCT01494922 Org: User:
Start: 12/08/11 End: 09/10/13 Due: 09/10/14

Efficacy and Safety Evaluation of AN2690 Topical Solution to Treat Onychomycosis of the Toenail

Phase: N/A Priority: Normal
NCT ID: NCT01270971 Org: User:
Start: 12/01/10 End: 01/08/13 Due: 01/08/14

Retrospective Epidemiology Study Of ALK Rearrangement In Non-Small Cell Lung Cancer Patients In The Middle East & North Africa

Phase: N/A Priority: Normal
NCT ID: NCT02304406 Org: User:
Start: 01/21/15 End: 02/11/18 Due: 02/11/19

A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Levofloxacin for the Treatment of Mild to Moderate Pneumonia in Adult Patients

Phase: N/A Priority: Normal
NCT ID: NCT00643734 Org: User:
Start: 04/30/03 End: 04/30/04 Due: 04/30/05

Effectiveness of ABRYSVO® Maternal Respiratory Syncytial Virus (RSV) Vaccine Against RSV in Infants in Western Pennsylvania

Phase: N/A Priority: Normal
NCT ID: NCT06813872 Org: User:
Start: 02/24/25 End: 07/31/25 Due: 07/31/26

Determine Effect of Enzalutamide (MDV3100) on the Androgen Signaling Pathway in Correlation With the Anti-tumor Effects of Enzalutamide

Phase: N/A Priority: Normal
NCT ID: NCT01091103 Org: User:
Start: 02/18/10 End: 08/31/13 Due: 08/31/14

Pharmacokinetics And Dialysability Of CP-690,550 In Subjects With End-Stage Renal Disease

Phase: N/A Priority: Normal
NCT ID: NCT01710020 Org: User:
Start: 02/28/03 End: 06/30/03 Due: 06/30/04

Study Of SU011248 In Combination With Docetaxel And Trastuzumab In Patients With Advanced Breast Cancer HER-2 Positive

Phase: N/A Priority: Normal
NCT ID: NCT00372424 Org: User:
Start: 12/31/06 End: 09/30/11 Due: 09/30/12

Evaluate Taste and Relative Bioavailability of Two Microsphere Formulations of Crizotinib in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT03978143 Org: User:
Start: 06/12/19 End: 10/17/19 Due: 10/17/20